Alamar Biosciences, Inc. Common Stock (ALMR) Stock
Key stats
- Market cap
- $2.20B
- Price / Earnings ratio
- -73.4x
- EPS (TTM)
- -$2.58
- Volume
- Loading
- 52-week high
- $39.61
- 52-week low
- $18.85
Source: third-party data provider, as of November 13, 2026
Compare with ALMR
Recent news

Alamar Biosciences Q3 Earnings Call Highlights
Alamar Biosciences Q3 Earnings Call Highlights
ALMR

Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ALMR

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
ALMR

Alamar Biosciences Q2 Earnings Call Highlights
Alamar Biosciences Q2 Earnings Call Highlights
ALMR
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 53.91
- MACD 12/26/9
- 0.18
- EMA 9 of MACD
- -0.01
- MACD histogram
- 0.20
- SMA 50
- $30.22
- Price above SMA 50
- EMA 50
- $29.87
- Price above EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Alamar Biosciences Q3 Earnings Call Highlights
Alamar Biosciences Q3 Earnings Call Highlights
ALMR

Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ALMR

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
ALMR

Alamar Biosciences Q2 Earnings Call Highlights
Alamar Biosciences Q2 Earnings Call Highlights
ALMR

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
ALMR

Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut
Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut
ALMR
News tone: automated (AI) classification of the article's content, not a price prediction.
About Alamar Biosciences, Inc. Common Stock
Alamar Biosciences is a commercial-stage proteomics company on a mission to power precision proteomics to enable the earliest detection of disease. The company is establishing a gold standard in protein detection and analysis through its proprietary NULISA technology, purpose-built to address the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Yuling Luo Ph.D. | Co-Founder, Chairman & CEO | 1964 |
| Dr. Shiping Chen Ph.D. | Co-Founder, COO & Director | 1963 |
| Mr. Justin J. McAnear | Chief Financial Officer | 1976 |
| Mr. Timothy Ogden White J.D. | President | 1968 |
| Ms. Yiyuan Yin Ph.D. | Founder, VP of Technology & Acting Secretary | — |
| Dr. Xiao-Jun Ma Ph.D. | Chief Technology Officer | — |
| Dr. Stephen A. Williams M.D., Ph.D. | Chief Scientific Officer | 1960 |
| Ms. Carrie Mendivil | Vice President of Investor Relations & Corporate Communications | — |
| Mr. Alex Forrest-Hay | Senior Vice President of Sales | — |
| Ms. Anna Berdine | Senior Vice President of Marketing | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 53.91
- MACD 12/26/9
- 0.18
- EMA 9 of MACD
- -0.01
- MACD histogram
- 0.20
- SMA 50
- $30.22
- Price above SMA 50
- EMA 50
- $29.87
- Price above EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $36.00
- Average
- $36.00
- High
- $36.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +13.8 | -20.8 | +32.1 | -2.9 | +12.8 | +16.0 | -5.7 | +9.2 |



